<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03963310</url>
  </required_header>
  <id_info>
    <org_study_id>RDS_2019_8</org_study_id>
    <nct_id>NCT03963310</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis</brief_title>
  <acronym>OCTON2</acronym>
  <official_title>Evaluation and Follow-up of Optic Neuritis Not Related to Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The visual prognosis of optic neuritis not related to multiple sclerosis is unknown, both in&#xD;
      terms of functional recovery and evolution.&#xD;
&#xD;
      This prospective cohort study aim to assess the ophthalmological evolution of patients&#xD;
      presenting an episode of optic neuritis (NO) not related to a multiple sclerosis or to a&#xD;
      clinically isolated syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2020</start_date>
  <completion_date type="Anticipated">September 14, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 14, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity (ETDRS scale)</measure>
    <time_frame>1 year</time_frame>
    <description>Evolution over 1 year of the ophthalmological parameters of patients treated for an episode of optic neuritis not related to multiple sclerosis or a clinically isolated syndrome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness of the layers of the retina with Optical Coherent Tomography(OCT),</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Humphrey Visual Field Test</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Optic Neuritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen at the Adolphe de Rothschild Foundation for the first onset of an optic&#xD;
        neuritis not related to multiple sclerosis and clinically isolated syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  First onset of an optic neuritis lasting for less than 1 month&#xD;
&#xD;
          -  With a brain MRI that does not meet the MS criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contra-indication to MRI&#xD;
&#xD;
          -  Pregnant or lactating woman&#xD;
&#xD;
          -  History of known ipsilateral optic neuritis&#xD;
&#xD;
          -  Ophthalmologic comorbidity in the ipsilateral eye that may interfere with the&#xD;
             interpretation of the examinations&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain DESCHAMPS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD PhD</last_name>
    <phone>+33 1 48 03 64 31</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Am√©lie YAVCHITZ, MD</last_name>
    <phone>+33 1 48 03 64 54</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation A. de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain DESCHAMPS, MD</last_name>
      <email>rdeschamps@for.paris</email>
    </contact>
    <investigator>
      <last_name>Romain DESCHAMPS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 20, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2019</study_first_posted>
  <last_update_submitted>June 20, 2021</last_update_submitted>
  <last_update_submitted_qc>June 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Optic Neuritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

